Page 231 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer
P. 231

Appendix Table C1.3. Trends in mortality rates (per 100,000 person-yr unless otherwise stated) or survival (continued)
 Author   Database   Groups    1980-84   1985-89   1990-94   1995-99   2000-04   2005-10   Statistical   Notes
 Year   (yr)                                           analysis
 PMID
 28
 McDavid    SEER,   50-59   NA   0.8 (1969-  NA   -3.6         All results   The
 2004   NCHS   60-69   0.5 (1969-  90)   NA   (1990-   were             reporting of
 15192905   70-79   84)   1.8 (1984-  NA   99)         significant      specific
 ≥80   0.2(1969-  92)   2.9 (1987-  -5.6               with P<0.05.     time
 Annual   84)   1.7 (1984-  93)   (1992-                                intervals
 percentage   1.2 (1969-  92)   99)                                     was
 change of the   87)   NA   -4.4                                        determined
 mortality rate   (1992-                                                by joint-
 for each time   99)                                                    point
 period.         -3.4                                                   analysis.
                 (1993-
                 99)                                                    Additional
                                                                        information
                                                                        is
                                                                        presented
                                                                        in Figure 5
                                                                        of the
                                                                        paper.
 30
 Jani    SEER   40-49   36%   18%   1%   2%            NR               Estimated
 2008    ≥80   33%   17%   16%   17%                                    from graph.
 18845997   5-yr prostate-  (1979-83)   (1984-88)   (1989-93)   (1994-  Reported
 cancer specific   98)                                                  as survival.
 mortality                                                              Also data
                                                                        for other
                                                                        age deciles.




























 C-33
   226   227   228   229   230   231   232   233   234   235   236